Prevymis 480 mg in 24 mL Injection
RxNorm 1988661
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1988661 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Prevymis 480 mg in 24 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
24 mL letermovir 20 mg/ML Injection [Prevymis]
(Atom ID: 9701992)
SYPrescribable
Synonym (SY):
Prevymis 20 mg/ML per 24 mL Injection
(Atom ID: 9701994)
PSNPrescribable
Prescribable Name (PSN):
Prevymis 480 mg in 24 mL Injection
(Atom ID: 9701996)
SYPrescribable
Synonym (SY):
Prevymis 480 mg per 24 mL Injection
(Atom ID: 9701995)
Patient Education
Letermovir Injection
Letermovir injection is used to help prevent cytomegalovirus (CMV) infection and disease in certain people who have received a hematopoietic stem-cell transplant (HSCT; a procedure that replaces diseased bone marrow with healthy bone marrow) and are at increased risk of developing a CMV infection. Letermovir is in a class of medications called antivirals. It works by slowing the growth of CMV.
[Learn More]
* Please review the disclaimer below.